iRadimed (FRA:46K) Float Percentage Of Total Shares Outstanding: 64.84% (As of Jul. 11, 2026)


FRA:46K iRadimed Corp FRA:46K
87 GF Score
Price €84.50
GF Value €56.24
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is iRadimed Float Percentage Of Total Shares Outstanding?

iRadimed FRA:46K +1.81% 87 Float Percentage Of Total Shares Outstanding is 64.84% as of Jul. 11, 2026. GuruFocus rates FRA:46K with a GF Score™ of 87/100 and a GF Value™ of €56.24 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, iRadimed's float shares is 8.29 Mil. iRadimed's total shares outstanding is 12.78 Mil. iRadimed's float percentage of total shares outstanding is 64.84%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, iRadimed's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, iRadimed's Institutional Ownership is 32.82%.

FRA:46K
87GF Score
iRadimed Corp FRA:46K
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

iRadimed Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

iRadimed's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=8.29/12.78
=64.84%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 64.84% mean?
iRadimed (FRA:46K) has a Float Percentage Of Total Shares Outstanding of 64.84% as of Jul. 11, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on iRadimed and its competitors.
Is iRadimed's Float Percentage Of Total Shares Outstanding too high?
iRadimed's current Float Percentage Of Total Shares Outstanding is 64.84%. Overall, iRadimed has a GF Score™ of 87/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does iRadimed's Float Percentage Of Total Shares Outstanding compare to AVNS and LMRI?
iRadimed's Float Percentage Of Total Shares Outstanding of 64.84% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Medical Devices & Instruments company?
A good Float Percentage Of Total Shares Outstanding depends on the Medical Devices & Instruments industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on iRadimed and its competitors. iRadimed's current Float Percentage Of Total Shares Outstanding is 64.84%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iRadimed stock overvalued right now?
Based on GuruFocus' analysis, iRadimed (FRA:46K) is currently considered Significantly Overvalued. The stock's GF Value™ is €56.24, compared to a current price of €84.50 — trading 50.2% above its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 64.84%. iRadimed's overall GF Score™ is 87/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For iRadimed (FRA:46K), the current Float Percentage Of Total Shares Outstanding is 64.84% as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is iRadimed (FRA:46K) Overvalued in 2026?

Based on GuruFocus' analysis, iRadimed stock appears to be overvalued. The current stock price of €84.50 is trading 50.2% above its estimated GF Value™ of €56.24. GuruFocus considers iRadimed to be Significantly Overvalued.

Key valuation signals for FRA:46K:

  • Float Percentage Of Total Shares Outstanding: 64.84%
  • GF Value™: €56.24 vs. price of €84.50 (50.2% above fair value)
  • GF Score™: 87/100 with 6 warning signs

No single metric tells the full story. See the FRA:46K stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

iRadimed Business Description

Other Exchanges IRMD:USA
Address 12705 Ingenuity Drive, Orlando, FL, USA, 32826
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.
87GF Score

Get the complete analysis for FRA:46K

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€84.50
Price
€56.24
GF Value